PHIO PHARMACEUTICALS CORP's ticker is PHIO and the CUSIP is 71880W303. A total of 18 filers reported holding PHIO PHARMACEUTICALS CORP in Q1 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $11,000 | 0.0% | 19,464 | +26.6% | 0.00% | 0.0% |
| Q2 2022 | $11,000 | -71.1% | 15,371 | -64.0% | 0.00% | -66.7% |
| Q1 2022 | $38,000 | -24.0% | 42,687 | -14.0% | 0.00% | -40.0% |
| Q4 2021 | $50,000 | -45.7% | 49,643 | +9.2% | 0.01% | -37.5% |
| Q3 2021 | $92,000 | +50.8% | 45,458 | +67.7% | 0.01% | +33.3% |
| Q2 2021 | $61,000 | +45.2% | 27,110 | +74.7% | 0.01% | +100.0% |
| Q1 2021 | $42,000 | -45.5% | 15,522 | -56.8% | 0.00% | -76.9% |
| Q3 2020 | $77,000 | – | 35,929 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VANGUARD GROUP INC | 154,536 | $57,487 | 0.00% |
| UBS Group AG | 23,029 | $8,521 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 22,398 | $8,332 | 0.00% |
| Cetera Investment Advisers | 75,000 | $27,900 | 0.00% |
| WELLS FARGO & COMPANY/MN | 93 | $35 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 106,917 | $39 | 0.00% |
| MORGAN STANLEY | 1,500 | $558 | 0.00% |
| BlackRock Inc. | 19 | $7 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 19,707 | $7,331 | 0.00% |